We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.
GLEN ALLEN, Va., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (โAdialโ or the โCompanyโ), a clinical-stage biopharmaceutical company focused on developing...
Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effect Marks final study needed for the upcoming FDA meeting for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -2.77777777778 | 1.08 | 1.16 | 1 | 92844 | 1.09843812 | CS |
4 | 0.0499 | 4.9895010499 | 1.0001 | 1.3 | 0.98 | 211557 | 1.11973292 | CS |
12 | 0.04 | 3.9603960396 | 1.01 | 1.3 | 0.9355 | 175054 | 1.08561097 | CS |
26 | -0.21 | -16.6666666667 | 1.26 | 3 | 0.9 | 1450803 | 1.2777569 | CS |
52 | -0.82 | -43.8502673797 | 1.87 | 4.12 | 0.765 | 2330676 | 1.96283585 | CS |
156 | -65.2 | -98.4150943396 | 66.25 | 76.25 | 0.765 | 1155829 | 5.93038657 | CS |
260 | -61.2 | -98.313253012 | 62.25 | 127 | 0.765 | 1011169 | 24.18802047 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions